WaveLight® EX500 Excimer Laser System for the Correction of Myopia Using InnovEyes™ in Conjunction With InnovEyes™ Sightmap

NACompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

March 9, 2020

Primary Completion Date

November 9, 2022

Study Completion Date

November 9, 2022

Conditions
Myopia
Interventions
DEVICE

WaveLight EX500 excimer laser system with InnovEyes sightmap

FDA approved stationary scanning-spot excimer laser system used during refractive surgery for the treatment of myopia, myopic astigmatism, hyperopia, hyperopic astigmatism, and mixed astigmatism. For this clinical study, the WaveLight EX500 software will be upgraded to include the InnovEyes treatment.

PROCEDURE

LASIK

Procedure that reshapes the front part of the eye (cornea) so that light traveling through it is properly focused on the back part of the eye (retina). The procedure will be performed using the WaveLight EX500 excimer laser system and data obtained from the InnovEyes sightmap.

DEVICE

InnovEyes sightmap

Non-contact ophthalmic diagnostic device that captures images of the eye and collects ocular data preoperatively to generate a patient-specific ablation profile for refractive correction surgery

Trial Locations (9)

29464

Alcon Investigative Site, Mt. Pleasant

46260

Price Vision Group, Indianapolis

57108

Alcon Investigative Site, Sioux Falls

63017

Alcon Investigative Site, St Louis

64154

Alcon Investigative Site, Kansas City

68135

Alcon Investigative Site, Omaha

75243

Alcon Investigative Site, Dallas

92122

Alcon Investigative Site, San Diego

20815-7018

Alcon Investigative Site, Chevy Chase

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT04219891 - WaveLight® EX500 Excimer Laser System for the Correction of Myopia Using InnovEyes™ in Conjunction With InnovEyes™ Sightmap | Biotech Hunter | Biotech Hunter